Biohaven (BHVN) Change in Cash (2021 - 2026)
Biohaven (BHVN) posted Change in Cash of $44.3 million for Q1 2026, little changed sequentially from $44.4 million in Q4 2025, and up 30053.74% YoY from N/an in Q1 2025.
Biohaven (BHVN) Change in Cash (2021 - 2026) Analysis & Trends
Biohaven has reported Change in Cash for 6 years, with the latest figure at $44.3 million in Q1 2026.
- Quarterly Change in Cash rose 30053.74% year-over-year to $44.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $174.4 million (up 307.04% YoY) and the FY2025 annual result came in at $130.2 million, up 187.07% from the prior year.
- Change in Cash steadied at $44.3 million in Q1 2026 per BHVN's latest filing, from $44.4 million in the prior quarter.
- Over five years, Change in Cash peaked at $191.2 million in Q4 2022 and troughed at -$154.3 million in Q3 2024.
- A 5-year average of $11.8 million and a median of $14.5 million in 2024 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2023 and 2026: Change in Cash slumped 376.63% in 2023, then jumped 30053.74% in 2026.
- Over 5 years, Change in Cash stood at $191.2 million in 2022, then plunged by 34.03% to $126.1 million in 2023, then tumbled by 88.49% to $14.5 million in 2024, then surged by 205.69% to $44.4 million in 2025, then decreased by 0.16% to $44.3 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $44.3 million, $44.4 million, and $19.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - | -36.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -36.48 Mn |
| Mar 31, 2026 | 44.33 Mn |
| Dec 31, 2025 | 44.40 Mn |
| Sep 30, 2025 | 19.39 Mn |
| Jun 30, 2025 | 66.31 Mn |
| Mar 31, 2025 | 147,000.00 |
| Dec 31, 2024 | 14.52 Mn |
| Sep 30, 2024 | -154.30 Mn |
| Jun 30, 2024 | 55.39 Mn |
| Mar 31, 2024 | -65.19 Mn |
| Dec 31, 2023 | 126.13 Mn |
| Sep 30, 2023 | -75.96 Mn |
| Jun 30, 2023 | 11.36 Mn |
| Mar 31, 2023 | -52.01 Mn |
| Dec 31, 2022 | 191.19 Mn |
| Sep 30, 2022 | 27.46 Mn |
| Jun 30, 2022 | -17.05 Mn |
| Mar 31, 2022 | -36.05 Mn |
| Dec 31, 2021 | -285.64 Mn |